[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100487027":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":31,"responsibleParty":110,"collaborators":10,"id":112,"slug":113,"hasResults":114,"nctId":115,"briefTitle":116,"officialTitle":117,"acronym":10,"eligibilityCriteria":118,"healthyVolunteers":114,"sex":119,"minAge":120,"maxAge":121,"enrollmentInfo":122,"targetDuration":10,"studyType":125,"phases":10,"briefSummary":126,"conditions":127,"keywords":129,"overallStatus":34,"whyStopped":10,"lastUpdateSubmitDate":134,"lastUpdatePostDateStruct":135,"startDateStruct":138,"completionDateStruct":140,"leadSponsor":142,"locationsCount":143},{"fullName":5,"class":6},"Novartis","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"ruxolitinib",null,"Patients currently receiving or going to receive Jakavi® treatment according to locally approved label",[13],"Other: ruxolitinib",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"OTHER","Prospective observational study. There is no treatment allocation. Patients prescribed with ruxolitinib in the commercial setting are eligible to enroll into this study.",[9],[20],"Jakavi",[22],{"name":23,"affiliation":23,"role":24},"Novartis Pharmaceuticals","STUDY_DIRECTOR",[26,30],{"name":23,"role":27,"phone":28,"phoneExt":10,"email":29},"CONTACT","+41613241111","novartis.email@novartis.com",{"name":23,"role":27,"phone":10,"phoneExt":10,"email":10},[32,45,54,63,71,76,81,84,92,97,102],{"facility":33,"status":34,"city":35,"state":36,"zip":37,"country":38,"countryCode":10,"cosmosGeoPoint":39,"geoPoint":44,"contacts":10},"Novartis Investigative Site","RECRUITING","Daegu","Dalseo gu","42602","South Korea",{"type":40,"coordinates":41},"Point",[42,43],128.59111,35.87028,{"lat":43,"lon":42},{"facility":33,"status":34,"city":46,"state":47,"zip":48,"country":38,"countryCode":10,"cosmosGeoPoint":49,"geoPoint":53,"contacts":10},"Wŏnju","Gangwon-do","26426",{"type":40,"coordinates":50},[51,52],127.94528,37.35139,{"lat":52,"lon":51},{"facility":33,"status":34,"city":55,"state":56,"zip":57,"country":38,"countryCode":10,"cosmosGeoPoint":58,"geoPoint":62,"contacts":10},"Seoul","Seocho gu","06591",{"type":40,"coordinates":59},[60,61],126.9784,37.566,{"lat":61,"lon":60},{"facility":33,"status":34,"city":64,"state":10,"zip":65,"country":38,"countryCode":10,"cosmosGeoPoint":66,"geoPoint":70,"contacts":10},"Busan","48108",{"type":40,"coordinates":67},[68,69],129.03004,35.10168,{"lat":69,"lon":68},{"facility":33,"status":34,"city":64,"state":10,"zip":72,"country":38,"countryCode":10,"cosmosGeoPoint":73,"geoPoint":75,"contacts":10},"49241",{"type":40,"coordinates":74},[68,69],{"lat":69,"lon":68},{"facility":33,"status":34,"city":64,"state":10,"zip":77,"country":38,"countryCode":10,"cosmosGeoPoint":78,"geoPoint":80,"contacts":10},"602-030",{"type":40,"coordinates":79},[68,69],{"lat":69,"lon":68},{"facility":33,"status":34,"city":82,"state":10,"zip":83,"country":38,"countryCode":10,"cosmosGeoPoint":10,"geoPoint":10,"contacts":10},"Jeollanam","519763",{"facility":33,"status":34,"city":85,"state":10,"zip":86,"country":38,"countryCode":10,"cosmosGeoPoint":87,"geoPoint":91,"contacts":10},"Jinju","660-702",{"type":40,"coordinates":88},[89,90],128.08472,35.19278,{"lat":90,"lon":89},{"facility":33,"status":34,"city":55,"state":10,"zip":93,"country":38,"countryCode":10,"cosmosGeoPoint":94,"geoPoint":96,"contacts":10},"02841",{"type":40,"coordinates":95},[60,61],{"lat":61,"lon":60},{"facility":33,"status":34,"city":55,"state":10,"zip":98,"country":38,"countryCode":10,"cosmosGeoPoint":99,"geoPoint":101,"contacts":10},"05505",{"type":40,"coordinates":100},[60,61],{"lat":61,"lon":60},{"facility":33,"status":34,"city":103,"state":10,"zip":104,"country":38,"countryCode":10,"cosmosGeoPoint":105,"geoPoint":109,"contacts":10},"Taegu","41944",{"type":40,"coordinates":106},[107,108],128.07278,34.88889,{"lat":108,"lon":107},{"type":111,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100487027","a-pms-of-jakavi-in-patients-with-steroid-refractory-graft-versus-host-disease-sr-gvhd-in-korea-100487027",false,"NCT05621733","A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea","A Post Marketing Surveillance of Jakavi® (Ruxolitinib) in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea","Inclusion Criteria:\n\n1. Patients who diagnosed with GvHD and currently receiving or going to receive Jakavi® treatment according to locally approved label\n2. Patients who are willing to provide written informed consent prior to study enrollment\n\nExclusion Criteria:\n\n1. Patients under 12 years old\n2. Patients with contraindication according to locally approved label of Jakavi®\n3. Patients who receive or are going to receive any investigational medicine during the observation period.","ALL","12 Years","100 Years",{"count":123,"type":124},127,"ESTIMATED","OBSERVATIONAL","This study is a prospective, open-label, multi-center, non-comparative, observational study to assess safety and effectiveness of Jakavi® (ruxolitinib) in the real-world clinical setting in Korean Graft-versus-Host disease (GvHD) patients",[128],"Graft-versus-Host Disease",[130,131,132,133,9,20],"Graft-versus-Host disease","GvHD","NIS","Korea","2025-08-06",{"date":136,"type":137},"2025-08-11","ACTUAL",{"date":139,"type":137},"2023-04-07",{"date":141,"type":124},"2026-05-09",{"name":23,"class":6},11]